Grandi Giovanni, Feliciello Lia, Sgandurra Alice, Pedrini Valeria, Guariglia Gloria, Ferrari Valentina, Del Duca Nicoletta, La Marca Antonio
Department of Medical and Surgical Sciences for Mother, Child and Adult, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
Eur J Contracept Reprod Health Care. 2025 Apr;30(2):78-86. doi: 10.1080/13625187.2024.2434846. Epub 2024 Dec 5.
The use of long-acting reversible contraceptives (LARCs) is increasing globally due to their higher ability to effectively prevent unintended pregnancies in comparison to short-acting reversible contraceptives (SARCs), especially in adolescence. LARCs include intrauterine devices (copper- or levonorgestrel-releasing) and subcutaneous implants. For LARCs application a dedicated training is needed. Particularly, this Expert Opinion is aiming to open to expert debates on the subcutaneous implant, in particular etonogestrel (ENG)-releasing one, as a cutting-edge form of hormonal contraception. It provides up-to-date guidance about practical advice and technical tips for the ENG implant insertion/removal derived from many years of clinical experience, along with recommendations for the management of unscheduled bleeding during contraception with this method.
与短效可逆避孕方法（SARCs）相比，长效可逆避孕方法（LARCs）能更有效地预防意外怀孕，因此其在全球的使用正在增加，尤其是在青少年中。LARCs包括宫内节育器（含铜或左炔诺孕酮）和皮下植入剂。使用LARCs需要专门的培训。特别是，本专家意见旨在开启关于皮下植入剂，尤其是释放依托孕烯（ENG）的皮下植入剂这一前沿激素避孕形式的专家辩论。它提供了基于多年临床经验的关于ENG植入/取出的实用建议和技术提示的最新指南，以及关于使用此方法避孕期间不规则出血管理的建议。
